Level D· Scientific groundwork from lab and animal studiesLaboratory StudyEurope PMCOpen access

Multifunctional Skin Dermal Extracellular Matrix Enabling Skin-Relevant Bioactivity for Tissue Remodeling, Hydration, and Anti-Hyperpigmentation

Kim YH., Park S., Cho JH., Han SY., Cho SW.

Laboratory Study on Skin Aging, published in J Microbiol Biotechnol (2026) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Laboratory Study
Journal
J Microbiol Biotechnol (2026)
Reported sample size
—
Source database
Europe PMC
PMID
41539855
PMCID
PMC12828126
DOI
10.4014/jmb.2601.01001

Abstract (original English)

Dermal extracellular matrix (ECM) deterioration is a central driver of skin aging, contributing to impaired elasticity, decreased moisturization, and uneven pigmentation. However, commonly used single-component ingredients and cell-derived bioactives provide limited coordinated cues and may therefore be insufficient to address these multifactorial processes. Here, we propose decellularized skin-derived ECM (skin ECM) as a multifunctional cosmetic ingredient through comparison with various existing cosmetic ingredients. Proteomic analysis shows that skin ECM retains diverse collagen subtypes along with glycoproteins and proteoglycans associated with dermal tensile properties and matrix regulation, more closely reflecting native dermal matrisome diversity than commercial collagen products. Skin ECM at an optimal concentration most effectively upregulates the expression of genes involved in ECM remodeling and hyaluronan-mediated hydration in human dermal fibroblasts. In comparative supplementation assay, skin ECM enhances fibroblast metabolic activity and induces the strongest expression of key ECM- and hydration-related genes among all tested ingredients. Interestingly, skin ECM reduces the expression of melanogenesis-related markers and melanin accumulation in melanoma cells under experimental conditions with α-melanocyte stimulating hormone treatment. Collectively, these findin

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
Extracellular MatrixFibroblastsSkinHumansCollagenHyaluronic AcidMelaninsCosmeticsSkin PigmentationProteomics

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research